Skip to search formSkip to main contentSkip to account menu

HMJ-38

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Cell death caused by quinazolinone HMJ-38 challenge in oral carcinoma CAL 27 cells: dissections of endoplasmic reticulum stress, mitochondrial dysfunction and tumor xenografts.
2014
2014
Effect of DNA damage response by quinazolinone analogue HMJ-38 on human umbilical vein endothelial cells
The present study aims to explore the mechanism of quinazolinone analogue HMJ-38-induced DNA damage in endothelial cells in vitro… 
2013
2013
Newly synthesized quinazolinone HMJ-38 suppresses angiogenetic responses and triggers human umbilical vein endothelial cell apoptosis through p53-modulated Fas/death receptor signaling.
2004
2004
Selective induction of G2/M arrest and apoptosis in HL-60 by a potent anticancer agent, HMJ-38.
We previously reported that HMJ-38 was the most potent 2-phenyl-4-quinozolinone derivative in inhibiting tubulin polymerization… 
1993
1993
2-(3''-Methoxyphenyl)-6-pyrrolidinyl-4-quinazolinone (HMJ-38) 對HL-60血癌細胞及; Studies on the Anticancer Mechanisms of 2-(3''-Methoxyphenyl)-6-pyrrolidinyl-4-quinazolinone (HMJ-38) in HL-60 cells and in…
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License